Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole

Stopped early · Phase 2

Conditions studied: Candidiasis, Oral, HIV Infections

In brief

The purpose of this study is to see if it is safe and effective to give L-743,872 to patients with thrush, an AIDS-related yeast infection of the mouth, that has not been cured with fluconazole treatment.

Key facts

Study ID

NCT00005920

Run by

Merck Sharp & Dohme LLC

People needed

70

Last updated by the study team

2005-06-24

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• You may be eligible for this study if you:
• Have thrush that has not responded to fluconazole treatment.
• Are 18-65 years old.

Where it is running

• Carol Sable — Rahway, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.